Nano-X Imaging Shares Are Trading Higher After Nano-X AI Received FDA 510(k) Approval for Its HealthFLD System for Detection of the Early Signs of Fatty Liver Disease
在Nano-X AI的用於檢測脂肪肝早期跡象的HealthFLD系統獲得美國食品藥品管理局510(k)批准後,Nano-X Imaging股價走高
Nano-X Imaging Shares Are Trading Higher After Nano-X AI Received FDA 510(k) Approval for Its HealthFLD System for Detection of the Early Signs of Fatty Liver Disease
在Nano-X AI的用於檢測脂肪肝早期跡象的HealthFLD系統獲得美國食品藥品管理局510(k)批准後,Nano-X Imaging股價走高
使用瀏覽器的分享功能,分享給你的好友吧